Compositions and methods for cancer immunotherapy

Details for Australian Patent Application No. 2011211457 (hide)

Owner Eisai R&D Management Co., Ltd.

Inventors Rossignol, Daniel P.; Ishizaka, Sally T.; Hawkins, Lynn D.; Fields, Scott

Agent Davies Collison Cave

Pub. Number AU-A-2011211457

Parent 2006241206

Filing date 15 August 2011

Wipo publication date 1 September 2011

International Classifications

C07K 1/00 (2006.01) General processes for the preparation of peptides

A61K 31/00 (2006.01)

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A01N 61/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action

A61K 38/24 (2006.01) Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

Event Publications

1 September 2011 Application Open to Public Inspection

  Published as AU-A-2011211457

1 September 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011211458-Implantable adjustable valve

2011211456-A gaming system and a method of gaming